Rigel Pharma (RIGL) Misses Q1 EPS by 2c

Rigel Pharma (NASDAQ: RIGL) reported Q1 EPS of ($0.16), $0.02 worse than the analyst estimate of ($0.14). Revenue for the quarter came in at $16.74 million versus the consensus estimate of $17.54 million.

For earnings history and earnings-related data on Rigel Pharma (RIGL) click here.

You May Also Be Interested In

• Klarna shares tumble on weak full-year revenue guidance
• AXIL Brands (AXIL) Tops Q4 EPS by 4c
• Keysight Technologies (KEYS) Tops Q3 EPS by 59c; Offers Guidance